TABLE 3.
Treatment | P value | ||||
---|---|---|---|---|---|
Item | Control | Met | Treat | Time | Treat × Time |
TCA cycle, AUC/mg protein | |||||
Acetyl-CoA | 7.14 ± 0.28 | 7.48 ± 0.28 | 0.442 | 0.685 | 0.813 |
Succinyl-CoA | 7.29 ± 0.18 | 7.29 ± 0.18 | 0.891 | 0.998 | 0.499 |
Malic acid | 12.8 ± 0.08 | 13.7 ± 0.08 | 0.093 | 0.764 | 0.716 |
α-Ketoglutaric acid | 10.21 ± 0.04 | 10.37 ± 0.04 | 0.084 | 0.375 | 0.526 |
Isocitric acid | 5.87 ± 0.08 | 6.22 ± 0.08 | 0.063 | 0.084 | 0.827 |
Met and folic acid cycle, AUC/mg protein | |||||
Glycine | 11.31 ± 0.05 | 11.21 ± 0.05 | 0.221 | 0.178 | 0.994 |
N-methylglycine | 8.09 ± 0.07 | 8.17 ± 0.07 | 0.184 | 0.123 | 0.516 |
N,N-dimethylglycine | 11.2 ± 0.16 | 11.2 ± 0.16 | 0.822 | 0.404 | 0.324 |
Betaine | 9.24 ± 0.08 | 9.28 ± 0.08 | 0.814 | 0.002 | 0.403 |
Met | 11.1 ± 0.06 | 11.3 ± 0.06 | 0.080 | 0.323 | 0.994 |
S-5′-adenosylmethionine | 10.5 ± 0.21 | 10.3 ± 0.21 | 0.492 | 0.034 | 0.482 |
S-5′-adenosylhomocysteine | ND | ND | |||
5-Methyltetrahydrofolic acid | 7.85 ± 0.28 | 8.03 ± 0.28 | 0.564 | 0.010 | 0.510 |
Tetrahydrofolic acid | ND | ND | |||
Folic acid | ND | ND | |||
Vitamin B-12 | ND | ND | |||
Adenosine | 9.21 ± 0.21 | 9.29 ± 0.21 | 0.822 | 0.301 | 0.674 |
Transsulfuration pathway, AUC/mg protein | |||||
Serine | 11.83 ± 0.11 | 11.89 ± 0.11 | 0.743 | 0.630 | 0.202 |
Hypotaurine | 9.38 ± 0.15 | 9.15 ± 0.15 | 0.284 | 0.181 | 0.443 |
Cysteine | 9.24 ± 0.09 | 9.27 ± 0.09 | 0.390 | 0.253 | 0.564 |
Homocysteine | ND | ND | |||
Vitamin B-6 | ND | ND | |||
Cystathionine | 9.35 ± 0.14 | 9.36 ± 0.14 | 0.961 | 0.934 | 0.245 |
Glutathione | 6.96 ± 0.46 | 8.31 ± 0.46 | 0.048 | 0.403 | 0.436 |
Taurine | 9.74 ± 0.08 | 9.99 ± 0.08 | 0.101 | 0.305 | 0.891 |
Cysteinesulfinic acid | 7.07 ± 0.28 | 6.83 ± 0.28 | 0.564 | 0.274 | 0.638 |
Values are means ± pooled SEMs, n = 10 per treatment group. ND, not detected; TCA, tricarboxylic acid.